Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China
- DOI
- 10.1002/cam4.70368
- Published
- 2024-11
- Container
- Cancer Medicine
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/cam4.70368,
title = {Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China},
author = {Siming Li and Yanxia Shi and Haiying Dong and Hongqian Guo and Yu Xie and Zhongquan Sun and Xiaoping Zhang and Eric Kim and Jun Zhang and Yue Li and Chenming Xu and Haishan Kadeerbai and Sue Lee and Seema Gorla and Jun Guo and Xinan Sheng},
year = {2024},
journal = {Cancer Medicine},
doi = {10.1002/cam4.70368},
url = {https://doi.org/10.1002/cam4.70368}
}RIS
TY - JOUR TI - Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China AU - Siming Li AU - Yanxia Shi AU - Haiying Dong AU - Hongqian Guo AU - Yu Xie AU - Zhongquan Sun AU - Xiaoping Zhang AU - Eric Kim AU - Jun Zhang AU - Yue Li AU - Chenming Xu AU - Haishan Kadeerbai AU - Sue Lee AU - Seema Gorla AU - Jun Guo AU - Xinan Sheng PY - 2024 JO - Cancer Medicine DO - 10.1002/cam4.70368 UR - https://doi.org/10.1002/cam4.70368 ER -
APA
Li, S., Shi, Y., Dong, H., Guo, H., Xie, Y., Sun, Z., Zhang, X., Kim, E., Zhang, J., Li, Y., Xu, C., Kadeerbai, H., Lee, S., Gorla, S., Guo, J., & Sheng, X. (2024). Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China. Cancer Medicine. https://doi.org/10.1002/cam4.70368
Source records
- crossref · retrieved 2026-09-26T22:50:08.813Z